BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 19595057)

  • 1. [Insulin release and daily glucose change in polycystic ovary syndrome women with normal glucose tolerance].
    Tao MF; Zhu JP; Zhou J; Lu W; Qin W; Teng YC; Jia WP
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):659-63. PubMed ID: 19595057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
    Yang XF; Ren FR; Guo SP
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
    Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
    Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of glycometabolism in the first-degree relatives of type 2 diabetes patients assessed by continuous glucose monitoring system].
    Chen LL; Li Q; Wang W; Cui C; Yu P; Bao LL; Wang J; Zhou J; Bao YQ; Jia WP; Sun YQ; Zhang JC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):655-8. PubMed ID: 19595056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative diagnostic characteristics of carbohydrate metabolism disorders in women with polycystic ovary syndrome (PCOS)].
    Orbetsova M; Orbetsova V; Kamenov Z; Kolarov G; Andreeva M; Genchev G; Zakharieva S; Borisov I
    Akush Ginekol (Sofiia); 2003; 42(4):10-5. PubMed ID: 14577361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.
    Lewandowski KC; Szosland K; O'Callaghan C; Tan BK; Randeva HS; Lewinski A
    Mol Genet Metab; 2005 May; 85(1):61-9. PubMed ID: 15862282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.
    Berria R; Gastaldelli A; Lucidi S; Belfort R; De Filippis E; Easton C; Brytzki R; Cusi K; Jovanovic L; DeFronzo R
    Clin Pharmacol Ther; 2006 Aug; 80(2):105-14. PubMed ID: 16890572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
    Svendsen PF; Nilas L; Nørgaard K; Jensen JE; Madsbad S
    Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Insulin resistance in obese and non-obese patients with polycystic ovary syndrome. Possible role in the pathogenesis of the disease].
    Vagiri D; Barletta C; Cioli I; Scavo D
    Minerva Endocrinol; 1994 Mar; 19(1):5-12. PubMed ID: 8035770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for insulin resistance in women with polycystic ovarian syndrome.
    Heald A; Whitehead S; Anderson S; Cruickshank K; Riste L; Laing I; Rudenski A; Buckler H
    Gynecol Endocrinol; 2005 Feb; 20(2):84-91. PubMed ID: 15823827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired beta-cell compensation to dexamethasone-induced hyperglycemia in women with polycystic ovary syndrome.
    Ehrmann DA; Breda E; Corcoran MC; Cavaghan MK; Imperial J; Toffolo G; Cobelli C; Polonsky KS
    Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E241-6. PubMed ID: 14665448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired growth hormone secretion after glucose loading in non-obese women with polycystic ovary syndrome, possibly related to androgen but not insulin and free fatty acids.
    Takeuchi T; Tsutsumi O; Taketani Y
    Gynecol Endocrinol; 2007; 23(8):468-73. PubMed ID: 17852425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive hypoglycemia in lean young women with PCOS and correlations with insulin sensitivity and with beta cell function.
    Altuntas Y; Bilir M; Ucak S; Gundogdu S
    Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):198-205. PubMed ID: 15808380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tryptophan 64 --> arginine polymorphism of beta-3-adrenergic receptor in Chilean women with polycystic ovary syndrome.
    Pérez-Bravo F; Echiburú B; Maliqueo M; Santos JL; Sir-Petermann T
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):126-31. PubMed ID: 15670186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome].
    Wang Y; Mao WW; Chen YJ; Li MZ; Qiao J; Wang LN
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):756-60. PubMed ID: 18307903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
    Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome.
    Carmina E; Lobo RA
    Fertil Steril; 2004 Sep; 82(3):661-5. PubMed ID: 15374711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.